These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6169799)

  • 1. Interactions between polymerized human albumin, hepatitis B surface antigen, and complement: I. Binding of polyalbumin to Clq.
    Milich DR; Papas ED; Bhatnagar PK; Vyas GN
    J Med Virol; 1981; 7(3):181-92. PubMed ID: 6169799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between polymerized human albumin, hepatitis B surface antigen, and complement: II. Involvement of Clq in or near the hepatitis B surface antigen receptor for polyalbumin.
    Milich DR; Bhatnagar PK; Papas ED; Vyas GN
    J Med Virol; 1981; 7(3):193-204. PubMed ID: 6270277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between various polymerized human albumins and hepatitis B surface antigen.
    Yu MW; Finlayson JS; Shih JW
    J Virol; 1985 Sep; 55(3):736-43. PubMed ID: 4020964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the interaction between polymerized human albumin and hepatitis B surface antigen.
    Milich DR; Gottfried TD; Vyas GN
    Gastroenterology; 1981 Aug; 81(2):218-25. PubMed ID: 6165643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and plasma fibronectin binds to complement reacted immune complexes primarily via Clq.
    Baatrup G; Svehag SE
    Scand J Immunol; 1986 Nov; 24(5):583-90. PubMed ID: 3097811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ionic strength, EDTA concentration, endogenous C1q and polyanions on the 125I-C1q-binding test.
    Hack CE; Huijbregts CC; Paardekooper J
    J Immunol Methods; 1984 Aug; 72(1):197-206. PubMed ID: 6205096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A frameshift mutation in the pre-S region of the human hepatitis B virus genome allows production of surface antigen particles but eliminates binding to polymerized albumin.
    Persing DH; Varmus HE; Ganem D
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3440-4. PubMed ID: 3858831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the mechanism of Clq binding to antibody-I. aggregation and/or distortion of IgG vs combining site-transmitted effects.
    Liberti PA; Bausch DM; Schoenberg LM
    Mol Immunol; 1982 Jan; 19(1):143-9. PubMed ID: 6176855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemagglutination and immunofluorescence studies on polymerized human serum albumin binding activity in chronic hepatitis B virus infection.
    Mora I; Porres JC; Hernández Guio C; Gutiez J; Carreño V
    Hepatology; 1986; 6(1):14-9. PubMed ID: 3002939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of the polymerised and monomeric human serum albumin binding sites on hepatitis B surface antigen.
    Ishihara K; Waters JA; Pignatelli M; Thomas HC
    J Med Virol; 1987 Jan; 21(1):89-95. PubMed ID: 3794674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the binding sites for glutaraldehyde-polymerized albumin on purified woodchuck hepatocyte plasma membranes.
    Michalak TI; Bolger GT
    Gastroenterology; 1989 Jan; 96(1):153-66. PubMed ID: 2491821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1q has albumin binding activity but does not interfere in the hemagglutination test for anti-albumin antibodies.
    Onică D; Mihăescu S; Zamfir G; Barac D
    J Immunol Methods; 1983 Apr; 59(1):73-82. PubMed ID: 6339642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.
    Narumoto J
    Gastroenterol Jpn; 1981; 16(2):174-85. PubMed ID: 6971771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of hepatitis B surface antigen with polymerized human serum albumin.
    O'Neill SP
    J Med Virol; 1979; 4(3):177-85. PubMed ID: 536742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B surface antigen binds to human serum albumin cross-linked by transglutaminase.
    Thung SN; Wang DF; Fasy TM; Hood A; Gerber MA
    Hepatology; 1989 May; 9(5):726-30. PubMed ID: 2565285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of a high-affinity binding site for the globular head regions of the C1q complement protein on a human diploid fibroblast subtype.
    Bordin S; Page RC
    Mol Immunol; 1989 Jul; 26(7):677-85. PubMed ID: 2789337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin interacts with Clq, a subcomponent of the first component of complement.
    Isliker H; Bing DH; Lahan J; Hynes RO
    Immunol Lett; 1982 Jan; 4(1):39-43. PubMed ID: 6277780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common epitopes in Clq and collagen type II.
    Heinz HP; Rubin K; Laurell AB; Loos M
    Mol Immunol; 1989 Feb; 26(2):163-9. PubMed ID: 2465489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for histidine residues in the immunoglobulin-binding site of human Clq.
    Easterbrook-Smith SB
    Biosci Rep; 1983 Feb; 3(2):135-40. PubMed ID: 6221769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of aggregated human gamma globulin by Raji cells: C1q will enhance only if it is dissociated from the C1 macromolecular complex.
    Manthei U; Strunk RC
    Immunology; 1981 Jun; 43(2):287-92. PubMed ID: 6166545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.